Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-hodgkin Lymphoma. Lancet. 2017;390(10091):298–310.

Article  PubMed  Google Scholar 

Liu WP, Wang XP, Zheng W, Xie Y, Tu MF, Lin NJ, et al. Incidence, clinical characteristics, and outcome of interstitial Pneumonia in patients with Lymphoma. Ann Hematol. 2018;97(1):133–9.

Article  PubMed  Google Scholar 

Salmasi G, Li M, Sivabalasundaram V, Panzarella T, Tsang R, Kukreti V, et al. Incidence of pneumonitis in patients with non-hodgkin Lymphoma receiving chemoimmunotherapy with rituximab. Leuk Lymphoma. 2015;56(6):1659–64.

Article  CAS  PubMed  Google Scholar 

Zhou T, Shen Q, Peng H, Chao T, Zhang L, Huang L, et al. Incidence of interstitial pneumonitis in non-hodgkin’s Lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. Ann Hematol. 2018;97(1):141–7.

Article  CAS  PubMed  Google Scholar 

Meng YN, Wang S, Shi Q, Xu PP, Cheng S, Wang L, et al. [Interstitial Pneumonia in patients with diffuse large B-cell Lymphoma receiving RCHOP and RCDOP regimens]. Zhonghua Xue Ye Xue Za Zhi. 2019;40(12):1015–20.

CAS  PubMed  Google Scholar 

Peerzada MM, Spiro TP, Daw HA. Pulmonary toxicities of biologics: a review. Anticancer Drugs. 2010;21(2):131–9.

Article  CAS  PubMed  Google Scholar 

Wu Y, Jia Y, Xu J, Shuai X, Wu Y. Fatal interstitial lung Disease induced by rituximab-containing chemotherapy, treatment with TNF-alpha antagonist and cytokine profiling: a case-report and review of the literature. J Clin Pharm Ther. 2013;38(3):249–53.

Article  CAS  PubMed  Google Scholar 

Tan J, Ni X. TNF-alpha antagonist may not be suitable for severe rituximab-induced interstitial lung Disease. J Clin Pharm Ther. 2015;40(3):249–50.

Article  CAS  PubMed  Google Scholar 

Li C, Lu F, Lei T, Yu H, Chen X, Peng S, et al. Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial Pneumonia in patients with B-cell Lymphoma on chemotherapy. BMC Cancer. 2020;20(1):742.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Lu F, Lei T, Yu H, Yang H. Clinical features, treatment and risk factors for interstitial Pneumonia in B-cell non-hodgkin Lymphoma patients. Transl Cancer Res. 2020;9(9):5139–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneumocystis Pneumonia in patients treated with rituximab. Chest. 2013;144(1):258–65.

Article  CAS  PubMed  Google Scholar 

Jiang XQ, Fang L, Mei XD, Wang XJ, Bao MH. Pneumocystis Jiroveci Pneumonia in patients with Non-hodgkin’s Lymphoma after Rituximab-containing regimen: two cases of report and literature review. J Thorac Disease. 2013;5(4):E162–6.

Google Scholar 

Venhuizen AC, Hustinx WN, van Houte AJ, Veth G, van der Griend R. Three cases of Pneumocystis Jirovecii Pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-hodgkin’s Lymphoma. Eur J Haematol. 2008;80(3):275–6.

Article  PubMed  Google Scholar 

Lee JY, Kang M, Suh KJ, Kim JW, Kim SH, Kim JW, et al. Pneumocystis Jirovecii Pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP. Mycoses. 2021;64(1):60–5.

Article  CAS  PubMed  Google Scholar 

Azadeh N, Limper AH, Carmona EM, Ryu JH. The role of Infection in interstitial Lung Diseases: a review. Chest. 2017;152(4):842–52.

Article  PubMed  Google Scholar 

Richter AG, Stockley RA, Harper L, Thickett DR. Pulmonary Infection in Wegener granulomatosis and Idiopathic Pulmonary Fibrosis. Thorax. 2009;64(8):692–7.

Article  CAS  PubMed  Google Scholar 

Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, et al. The role of bacteria in the pathogenesis and progression of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2014;190(8):906–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vidal S, de la Horra C, Martin J, Montes-Cano MA, Rodriguez E, Respaldiza N, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung Disease. Clin Microbiol Infect. 2006;12(3):231–5.

Article  CAS  PubMed  Google Scholar 

Blivet S, Philit F, Sab JM, Langevin B, Paret M, Guerin C, et al. Outcome of patients with Idiopathic Pulmonary Fibrosis admitted to the ICU for Respiratory Failure. Chest. 2001;120(1):209–12.

Article  CAS  PubMed  Google Scholar 

Chioma OS, Drake WP. Role of Microbial Agents in Pulmonary Fibrosis. Yale J Biol Med. 2017;90(2):219–27.

CAS  PubMed  PubMed Central  Google Scholar 

Fishman JA, Gans H, Practice ASTIDC. Pneumocystis Jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9):e13587.

Article  Google Scholar 

Douglas AP, Smibert OC, Bajel A, Halliday CL, Lavee O, McMullan B, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51(Suppl 7):143–76.

Article  PubMed  Google Scholar 

Shiraishi Y, Kryukov K, Tomomatsu K, Sakamaki F, Inoue S, Nakagawa S, et al. Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing. Infect Dis (Lond). 2021;53(6):450–9.

Article  CAS  PubMed  Google Scholar 

Chen Z, Cheng H, Cai Z, Wei Q, Li J, Liang J, et al. Identification of Microbiome Etiology Associated with Drug Resistance in Pleural Empyema. Front Cell Infect Microbiol. 2021;11:637018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for Pathogen Detection. Annu Rev Pathol. 2019;14:319–38.

Article  CAS  PubMed  Google Scholar 

Duan H, Li X, Mei A, Li P, Liu Y, Li X, et al. The diagnostic value of metagenomic next rectanglegeneration sequencing in infectious Diseases. BMC Infect Dis. 2021;21(1):62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi C, Hountras P, Pickens CO, Walter JM, Kruser JM, Singer BD, et al. Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing. J Med Microbiol. 2019;68(7):996–1002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Feng W, Ye K, Guo L, Xia H, Guan Y, et al. Application of Metagenomic Next-Generation sequencing in the diagnosis of pulmonary infectious pathogens from Bronchoalveolar Lavage Samples. Front Cell Infect Microbiol. 2021;11:541092.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Zhao Y, Shang Y, Lin Z, Xu G, Bai B et al. The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe Pneumonia. J Med Microbiol. 2021;70(1).

Peng JM, Du B, Qin HY, Wang Q, Shi Y. Metagenomic next-generation sequencing for the diagnosis of suspected Pneumonia in immunocompromised patients. J Infect. 2021;82(4):22–7.

Article  CAS  PubMed  Google Scholar 

Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious Diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2022;53:100906.

Article  CAS  PubMed  Google Scholar 

Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.

Article  PubMed  PubMed Central  Google Scholar 

Park SW, Baek AR, Lee HL, Jeong SW, Yang SH, Kim YH, et al. Korean guidelines for diagnosis and management of interstitial Lung Diseases: part 1. Introduction Tuberc Respir Dis (Seoul). 2019;82(4):269–76.

Article  PubMed  Google Scholar 

Park SW, Baek AR, Lee HL, Jeong SW, Yang SH, Kim YH, et al. Korean guidelines for diagnosis and management of interstitial Lung Diseases: part 1. Introduction Tuberculosis and Respiratory Diseases. 2019;82(4):269–76.

Article  PubMed  Google Scholar 

Lee SH, Yeo Y, Kim TH, Lee HL, Lee JH, Park YB, et al. Korean guidelines for diagnosis and management of interstitial Lung Diseases: part 2. Idiopathic Pulmonary Fibrosis. Tuberc Respir Dis (Seoul). 2019;82(2):102–17.

Article  PubMed  Google Scholar 

Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung Disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.

Article  PubMed  Google Scholar 

Li Y, Sun B, Tang X, Liu YL, He HY, Li XY, et al. Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients. Eur J Clin Microbiol Infect Dis. 2020;39(2):369–74.

Article  CAS  PubMed